Global CRISPR Gene Detection and Diagnostic Markets, 2022-2027: Industry Structure - Biotechnology Industry, In-Vitro Diagnostics, Cannabilization, PCR and In Vitro Diagnostics, & The Food Industry

News provided by

Jan 19, 2022, 15:15 ET

DUBLIN, Jan. 19, 2022 /PRNewswire/ -- The "CRISPR Gene Detection and Diagnostic Markets by Research, Clinical Lab, Consumer, Public Service & Other with Executive and Consultant Guides" report has been added to ResearchAndMarkets.com's offering.

The market has just gotten started with a handful of small startup companies. Expect the big players to start taking notice. CRISPR is even helping in the battle against Anti Microbial Resistance. Learn about this market including the issues and outlooks.

The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success. It could possibly displace most frontline test protocols AND save money at the same time.

CRISPR is not just about changing genes. CRISPR identifies unique genetic material instantly, accurately and cheaply. A whole new world of identification and diagnostics opens up. Find out exactly what kind of cold or flu you have. Find out exactly what kind of fish you are eating. Instantly detect the presence of unwelcome bacteria, anywhere. A new COVID test is already available.

Will this disruptive technology change the world of In Vitro Diagnostics? What is the impact on Clinical Laboratories? How will social norms be affected?

The report includes five year market forecasts.

CRISPR Recent Developments

CRISPR SARS-CoV-2 Test Could be used for Asymptomatic Screening
Mammoth Biosciences, Agilent to Comarket CRISPR-Based SARS-CoV-2 Test
Pandemic Accelerates Development of CRISPR Diagnostics
COVID Assays Use CRISPR and Smartphones
ERS Genomics Licenses CRISPR Patents to Vivlion
Mammoth Bio Signs Commercialization Deal for SARS CoV-2 Test
ERS Genomics, FASMAC Sign Deal to Commercialize CRISPR-Cas9 Research Reagents
The Nobel Prize in Chemistry 2020
Caspr Biotech Developing COVID Dx

Market Trends

Factors Driving Growth

Cost, Accuracy and Speed
The Economies of Multiplexing with Nucleic Acids
The New Agriculture
Pandemics and Pathogens
Health and Self - A Sea Change in Healthcare

Factors Limiting Growth

Ubiquitous PCR
The Shrinking Cost of All Things Genetic
Wellness has a downside
The Limits of Detection

Market Overview

Market Participants Play Different Roles

Instrument Manufacturer
Independent lab specialized/esoteric
Independent lab national/regional
Independent lab analytical
Public National/regional lab
Hospital lab
Physician lab
DTC Lab
Sequencing Labs
Audit body

Genetic Material Detection Markets, Examples and Discussion

Research Markets
Research Funding and Capital Expense
The Research Role of CRISPR
Clinical Laboratories - Accuracy, Cost and Speed
Multiplexing in the Lab and at the Point of Care
Consumer Diagnostics
The CRISPR Consumer
Why Consumers Like Multiplexing
Public Service Markets
Public Health
Public Security
Environmental Monitoring
AgriBio and Other Markets
AgriBio
Other Uses for CRISPR Gene Detection

Industry Structure

The Biotechnology Industry
In Vitro Diagnostics Industry
Cannabilization, PCR and In Vitro Diagnostics
The Food Industry

Key Companies

10x Genomics, Inc
Aelian Biotechnology
Agilent
Axxam
Beckman Coulter Diagnostics
Becton, Dickinson and Company
Binx Health
bioMerieux Diagnostics
Bio-Rad Laboratories, Inc
Caspr Biotech
ERS Genomics
FASMAC
Illumina
Janssen Diagnostics
Locus Biosciences
Mammoth Biosciences
NRGene
Roche Molecular Diagnostics
Sherlock Biosciences
Thermo Fisher Scientific Inc.
Vivlion

For more information about this report visit https://www.researchandmarkets.com/r/dh7rtk

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets